F

D

FUMAGALLI , D.

Last name: FUMAGALLI

First name: D.

2017 (v1)

Publication

Metadata-only

Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials

Solinas, C. Ceppi, M. Lambertini, M.

Background A relationship between baseline tumor-infiltrating lymphocytes (TIL) and outcomes has been described in HER2-positive breast cancer. Nevertheless, the magnitude of this association and whether this effect differs based on the type of anti-HER2 agent remain controversial. This meta-analysis investigated the association between...

Uploaded on: April 14, 2023